Prevalence and Socioeconomic Correlates of Adult Obesity in Europe: The Feel4Diabetes Study

Diamantis, Dimitrios V.; Karatzi, Kalliopi; Kantaras, Paris; Liatis, Stavros; Iotova, Violeta; Bazdraska, Yulia; Tankova, Tsvetalina; Cardon, Greet; Wikström, Katja; Rurik, Imre; Antal, Emese; Ayala-Marín, Alelí M.; Giménez-Legarre, Natalia; Makrilakis, Konstantinos; Μanios, Yannis

doi:10.3390/ijerph191912572

Cited by 9 publications

(8 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the ratio of overweight or obesity shows a high variability according to the different geographical region, such as 42.2% in the general adult population in the United States [ 3 ]; 44.8% among the Latin population in the United States [ 3 ]; 17.8% in the overall population in Dubai [ 4 ]; 21.6% in South African subjects [ 5 ] and 47.6% in Europe [ 6 ]. As a matter of fact, data from Central Eastern European region are more concerning than those from Western European countries; for instance, in the Hungarian population, the overweight (body mass index; BMI: ≥25 kg/m 2 ) and obesity (BMI: ≥30 kg/m 2 ) prevalence are approximately 35% and 20%, respectively [ 7 ]. Unfortunately, the estimated data are also very unfavorable, the World Obesity Atlas 2022 predicts that one billion people globally, including 1 in 5 women and 1 in 7 men, will be living with obesity by 2030 [ 8 ].…”

Section: Introductionmentioning

confidence: 99%

Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity

et al. 2023

View full text Add to dashboard Cite

Obesity is characterized by an excessive accumulation of fat leading to a plethora of medical complications, including coronary artery disease, hypertension, type 2 diabetes mellitus or impaired glucose tolerance and dyslipidemia. Formerly, several physiological roles of organokines, including adipokines, hepatokines, myokines and gut hormones have been described in obesity, especially in the regulation of glucose and lipid metabolism, insulin sensitivity, oxidative stress, and low-grade inflammation. The canonical effect of these biologically active peptides and proteins may serve as an intermediate regulatory level that connects the central nervous system and the endocrine, autocrine, and paracrine actions of organs responsible for metabolic and inflammatory processes. Better understanding of the function of this delicately tuned network may provide an explanation for the wide range of obesity phenotypes with remarkable inter-individual differences regarding comorbidities and therapeutic responses. The aim of this review is to demonstrate the role of organokines in the lipid and glucose metabolism focusing on the obese non-diabetic subgroup. We also discuss the latest findings about sarcopenic obesity, which has recently become one of the most relevant metabolic disturbances in the aging population.

show abstract

Section: Introductionmentioning

confidence: 99%

Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity

et al. 2023

View full text Add to dashboard Cite

show abstract

“…The disparity between vulnerable communities and the general population regarding their weight statuses has been recently studied in a multicentric study that included approximately 25,000 participants from low-socioeconomic-status communities from six European countries. The authors of the cited study created a three-variable score comprising unemployment, financial instability, and low education level (<12 years of formalized education), factors that were directly proportional to the probability of being overweight or obese, with overall rates of 34.5% and 15.8%, respectively [17]. The higher figures for both overweight and morbidly obese status in our study are plausibly related to the Romani's proximity to the more severe end of the socio-economic and cultural impoverishment scale among European communities [18][19][20].…”

Section: Discussionmentioning

confidence: 99%

Unveiling Health Inequalities: Exploring Metabolic Dysfunction in Rural Roma Communities

Crișan,

Avram,

Grapă

et al. 2024

Healthcare

View full text Add to dashboard Cite

Background: Europe’s largest ethnic minority, the Roma, are often confronted with substantial obstacles that result in health disparities. Research indicates that there are elevated rates of both communicable and non-communicable diseases, such as metabolic syndrome (MetS), among Roma communities, often linked to living conditions, limited education, or poverty. This study centers on remote rural Roma settlements in Romania, evaluating the prevalence of metabolic dysfunction, obesity, and liver steatosis while considering socio-economic and lifestyle factors. Methods: Over a period of 36 months, local visits to a total of 25 rural Roma communities were conducted, where a medical team gathered information through a standardized questionnaire and conducted a physical exam on every participant. Liver steatosis was also recorded with the help of a portable wireless ultrasound device. Results: Our study included 343 participants, with a predominance of female subjects, representing 72.5% (n = 249) of the patients. The prevalence of obesity, defined by a body mass index (BMI) above 30 kg/m2, was 32.2% (n = 111). Arterial hypertension was found to have a prevalence of 54.1% (n = 185), with de novo hypertension being observed in 19.2% patients (n = 66). Type 2 diabetes mellitus was found in 28.9% patients (n = 99), with 19.5% being de novo cases. The prevalence of hepatic steatosis was 57.2% (n = 111/194). A positive association between metabolic features and at-risk behaviors was found. Conclusions: This study underscores the transition from infectious to metabolic diseases in vulnerable communities and highlights the urgency of targeted public health strategies tailored to the unique needs of rural Roma populations, aiming to mitigate health disparities and promote equitable healthcare access.

show abstract

“…It is well known that mean BMI is higher among people with a lower lifetime socioeconomic status compared to those with a higher one, an association that is generally stronger among men than among women ( Newton et al, 2017 ). Moreover, the prevalence of obesity has been associated with higher unemployment rates throughout Europe and in Spain ( Diamantis et al, 2022 ). However, in our study, educational level and employment status do not seem to be independently related to the perception of discrimination and stigma due to obesity.…”

Section: Discussionmentioning

confidence: 99%

Assessment of obesity stigma and discrimination among Spanish subjects with a wide weight range: the OBESTIGMA study

Sánchez,

Ciudin,

Sánchez

et al. 2023

Front. Psychol.

View full text Add to dashboard Cite

IntroductionThis study aims to assess the extent of rejection and instances of stigmatization linked to obesity within the Spanish population, encompassing a diverse spectrum of weights ranging from normal weight to morbid obesity. Additionally, the study seeks to identify the primary factors influencing these experiences and further examines the impact of bariatric surgery on such dynamics.Materials and methodsMulticenter observational study with involving a total of 1,018 participants who were recruited from various Obesity Units. Negatives attitudes towards people with obesity were assessed through three questionnaires: (i) Antifat Attitudes Scale (AFA), (ii) Stigmatizing Situations Inventory (SSI) and (iii) Weight Bias Internalization Scale (WBIS). Subjects were categorized into four groups based on their BMI and history of prior bariatric surgery.ResultsThe cumulative score across all questionnaires (AFA, SSI and WBIS) exhibited a progressive increase, from participants with normal weight to those with obesity (p < 0.001 for all). Within the AFA questionnaire, males showed more rejection towards people with obesity than women, also perceiving obesity as a disease linked to a lack of willpower (p = 0.004 and p = 0.030, respectively). The overall SSI score was negatively associated with age (r = −0.080, p = 0.011), with young participants encountering more stigmatizing experiences than their adult counterparts. Neither employment status nor educational demonstrated a significant association with any of the questionnaires. Interestingly, patients who underwent lost weight following bariatric surgery did not exhibit improved outcomes.ConclusionIndividuals with obesity demonstrate a heightened level of aversion towards the disease compared to those with normal weight. Concurrently, the incidence of stigmatizing encounters displays a concerning escalation among younger individuals.

show abstract

Prevalence and Socioeconomic Correlates of Adult Obesity in Europe: The Feel4Diabetes Study

Cited by 9 publications

References 42 publications

Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity

Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity

Unveiling Health Inequalities: Exploring Metabolic Dysfunction in Rural Roma Communities

Assessment of obesity stigma and discrimination among Spanish subjects with a wide weight range: the OBESTIGMA study

Contact Info

Product

Resources

About